Search alternatives:
significant treatment » significant investment (Expand Search), significant enrichment (Expand Search), significant impairment (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
treatment decrease » treatment decreased (Expand Search), treatments decreased (Expand Search), treatment increases (Expand Search)
significant treatment » significant investment (Expand Search), significant enrichment (Expand Search), significant impairment (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
treatment decrease » treatment decreased (Expand Search), treatments decreased (Expand Search), treatment increases (Expand Search)
-
61
-
62
-
63
-
64
-
65
-
66
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
67
-
68
-
69
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
70
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
71
-
72
-
73
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
74
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
75
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
76
-
77
Pan-cancer analyses of ACADM expression and its prognostic significance in the TCGA database.
Published 2025Subjects: -
78
-
79
Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae
Published 2025“…Developing efficient and accurate detection of resistant strains is urgently needed for their management and treatment. We have developed the Multiplex Integrated RPA-CRISPR/Cas12a detection Assay (MIRCA) for simultaneous detection of Neisseria gonorrheae (<i>Ng</i>) and mutations with decreased susceptibility to cephalosporins. …”
-
80
RipU<sup>K60</sup> decreases microtubule abundance at 48 hours post infiltration.
Published 2024“…(B) Heterologous expression of RipU<sup>K60</sup> significantly decreased microtubule number compared to controls at 48 hpi in <i>N</i>. …”